In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Making Anesthesiology More Science, Less Art

Executive Summary

When it comes to monitoring patient consciousness levels during surgery, anesthesiology is as much art as science, traditionally relying on the anesthesiologist's judgment in the absence of instrumentation. The worst case result of this inexactitude, while rare, is everyone's worst nightmare, a condition called surgical awareness, where a patient is awake and can feel the pain but is paralyzed and unable to respond. The more common problem is the over-medication of patients, which results in accompanying side effects and longer recovery times. Aspect Medical has developed the first monitor to enable anesthesiologists to determine a patient's consciousness level to permit physicians to assess the amount of anesthesia necessary for sedation and track the risk of awareness. It's been a long haul for Aspect, which started in 1987 as a cardiology company and has survived a near bankruptcy and a pulled IPO along the way. But the result is the first major medical device IPO in nearly two years and a first mover advantage in a large market.

You may also be interested in...



Thermo Fisher Scientific, Hillrom To Acquire Diagnostics Companies To Bolster Portfolios

Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.

Cosmetic And Personal Care Trademark Review 19 January, 2021

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

CMS Extends National Medicare Coverage For Transcatheter Mitral Valve Repair

Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

ID1130879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel